Moderna and Pfizer rebound after FDA authorizes third COVID-19 booster shot for immunocompromised

Chip Somodevilla/Getty ImagesShares of Pfizer, Moderna, and BioNTech all rebounded on Friday, each jumping about 2%.The move higher came after the FDA authorized a third COVID-19 booster shot for the immunocompromised.The companies expect strong demand for its COVID-19 vaccine into 2022 and beyond.Sign up here for our daily newsletter, 10 Things Before the Opening Bell.Shares of Moderna, Pfizer, and BioNTech each jumped about 2% on Friday, rebounding from a sharp two-day decline experienced earl